These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 132638)

  • 21. [Correlations between complement degradation products and circulating immune complexes in human glomerulonephritis].
    Coppo R; De Marchi M; Alloatti S; Segoloni G; Giacchino F; Quarello F; Roccatello D; Bulzomi MR; Piccoli G
    Minerva Nefrol; 1979; 26(3):243-50. PubMed ID: 318057
    [No Abstract]   [Full Text] [Related]  

  • 22. Passive immune complex glomerulonephritis in mice: models for various lesions found in human disease. I. High avidity complexes and mesangiopathic glomerulonephritis.
    Germuth FG; Rodriguez E; Lorelle CA; Trump EI; Milano L; Wise O
    Lab Invest; 1979 Oct; 41(4):360-5. PubMed ID: 158674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modification of glomerular immune complex deposits.
    McCluskey RT
    Lab Invest; 1983 Mar; 48(3):241-4. PubMed ID: 6219247
    [No Abstract]   [Full Text] [Related]  

  • 24. C3 split products inhibit the binding of antigen-antibody-complement complexes to B lymphocytes.
    Eden A; Bianco C; Nussenzweig V; Mayer MM
    J Immunol; 1973 May; 110(5):1452-3. PubMed ID: 4540538
    [No Abstract]   [Full Text] [Related]  

  • 25. The glomerular deposition of soluble immune complexes prepared with reduced and alkylated antibodies and with intact antibodies in mice.
    Haakenstad AO; Striker GE; Mannik M
    Lab Invest; 1976 Sep; 35(3):293-301. PubMed ID: 134177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations of complement components in disease.
    Luskin AT; Tobin MC
    Am J Med Technol; 1982 Sep; 48(9):749-56. PubMed ID: 6215862
    [No Abstract]   [Full Text] [Related]  

  • 27. Recent advances in the immunological aspects of renal disease.
    Wilson CB
    Fed Proc; 1977 Jul; 36(8):2171-5. PubMed ID: 141379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune complex renal disease and human immunodeficiency virus infection.
    Cohen SD; Kimmel PL
    Semin Nephrol; 2008 Nov; 28(6):535-44. PubMed ID: 19013324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of the role of circulating antigen-antibody complexes in the pathogenesis of glomerular nephropathies].
    Favre H; Nydegger U; Zubler R; Mulli JC; Lambert PH; Cruchaud A
    Schweiz Med Wochenschr; 1977 Dec; 107(48):1781-3. PubMed ID: 929139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of immunoglobulin to complement receptors of human B cells.
    Abrahamsohn I; Nilsson UR; Abdou NI
    J Immunol; 1974 May; 112(5):1931-8. PubMed ID: 4594420
    [No Abstract]   [Full Text] [Related]  

  • 31. [Studies of complement, nephritic factor, and circulating immune complexes in chronic mesangiocapillary glomerulonephritis types I and II (author's transl)].
    Mirapeix E; Yagüe J; Vives J; Revert L
    Med Clin (Barc); 1981 Jun; 77(1):21-6. PubMed ID: 7253758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Determination of immune complexes in renal diseases (author's transl)].
    Smolen JS; Wolf A; Scherak O; Syre G; Pinggera W; Stummvoll HK; Leithner C; Menzel EJ
    Acta Med Austriaca; 1981; 8(2):37-41. PubMed ID: 6456639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigen-specific suppression of the experimental immune complex glomerulonephritis in rabbits by means of highly hot labelled antigen.
    Filipp G; Schumacher H; Dienes HP; Thoenes W; Biro G; Baumann B
    Allergol Immunopathol (Madr); 1984; 12(4):251-7. PubMed ID: 6209971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The disappearance kinetics of soluble immune complexes prepared with reduced and alkylated antibodies and with intact antibodies in mice.
    Haakenstad AO; Mannik M
    Lab Invest; 1976 Sep; 35(3):283-92. PubMed ID: 134176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Value of serological studies of the complement system in glomerulonephritis].
    Szewczyk Z; Klinger M; Strychowski J
    Pol Tyg Lek; 1982 Aug; 37(29-30):869-73. PubMed ID: 6218487
    [No Abstract]   [Full Text] [Related]  

  • 36. Nephritogenic immune reactions involving immune complex formation in the circulation and in situ within the kidney.
    Wilson CB; Neale TJ; Holdsworth SR
    Aust N Z J Med; 1981; 11(Suppl 1):88-93. PubMed ID: 6455118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Criticism of the circulating immune complex therapy. Applications in nephrology].
    Sobel A
    Ann Med Interne (Paris); 1982; 133(5):314-9. PubMed ID: 6216843
    [No Abstract]   [Full Text] [Related]  

  • 38. Complement-mediated inhibition of immune precipitation in patients with immune complex diseases.
    Naama JK; Mitchell WS; Zoma A; Veitch J; Whaley K
    Clin Exp Immunol; 1983 Feb; 51(2):292-8. PubMed ID: 6220848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The pathogenetic role and clinical value of detecting circulating immune complexes in glomerulonephritis].
    Shilov EM; Leskov VP
    Ter Arkh; 1983; 55(6):127-33. PubMed ID: 6225208
    [No Abstract]   [Full Text] [Related]  

  • 40. [Role of hepatitis B viruses in the etiology of glomerulonephritis].
    Filimonova RG
    Ter Arkh; 1986; 58(2):137-40. PubMed ID: 2939584
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.